Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	82.37	73.57	40.34
Graham Fair Price	-7.29	3.75	4.04
PEG	37.45	-1.76	-2.81
Price/Book	10.89	2.04	1.84
Price/Cash Flow	119.37	-50.06	22.82
Prices/Earnings	34.73	27.00	20.04
Price/Sales	37.37	8.24	6.00
Price/FCF	119.37	-50.06	22.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-33.62	0.21	0.31
Operating Margin	-16.83	0.09	0.11
ROA	-15.54	0.01	0.02
ROE	0.02	0.02	-17.69
ROIC	0.02	0.02	-25.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.14	-52.33
Dividends QOQ	-0.90	-0.52	42.29
EBIT QOQ	0.07	-0.31	373.46
EPS QOQ	-0.07	-0.15	-115.38
FCF QOQ	24.88	-1.52	-93.91
Revenue QOQ	-0.06	-0.18	-181.97
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	27.83	34.05	22.32
Days Sales Outstanding (DSO)	108.22	133.07	22.97
Inventory Turnover	3.23	2.64	-18.25
Debt/Capitalization	0.07	0.06	-20.35
Quick Ratio	2.15	2.28	5.92
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.63	5.75	2.19
Cash	2.08	1.92	-7.74
Capex	0.02	-0.03	122.70
Free Cash Flow	0.45	-0.23	-48.34
Revenue	1.73	1.43	-17.51
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.41	2.62	9.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.11	-10.51	-29.54
Naive Interpretation	Member

06 - Financial Health · Bad

Rating